GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Research & Development

Bluemtec Co (XKRX:439580) Research & Development : ₩759 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bluemtec Co's Research & Development for the three months ended in Mar. 2024 was ₩293 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩759 Mil.

Bluemtec Co Research & Development Historical Data

The historical data trend for Bluemtec Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Research & Development Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
Research & Development
154.80 435.24 499.44

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial 183.38 226.06 263.06 -23.02 292.61

Bluemtec Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩759 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluemtec Co  (XKRX:439580) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bluemtec Co Research & Development Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bluemtec Co (XKRX:439580) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Website
https://www.bluemtec.co.kr
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines